ListarReumatoloxía por tema "Tanezumab"
Mostrando ítems 1-1 de 1
-
Subcutaneous tanezumab for osteoarthritis: is the early improvement in pain and function meaningful and sustained?
(Wiley, 2021-03-16)[Abstract] Background: To evaluate if early improvements in pain and function with subcuta-neous tanezumab are meaningful and sustained over 24 weeks. Methods: Patients with moderate- to- severe osteoarthritis (hip or ...